EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Single‐Amino‐Acid Ligand for LAT1: A Minimalist and Modular Platform for Lysosome‐Targeted Degradation of Membrane Proteins

Liquan Zhu, Ke Liu, Haotian Liu iD, Chaoqi He, Xiaozhen Liu, Xin Zeng, Misha Mao, Yuxiao Mu, Ying Li, Qinghui Zheng, Hongchao Tang iD, Da Qian iD und 1 weitere

Advanced Science · 2026

DOI: 10.1002/advs.76862 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, 2026. Verfasst von Liquan Zhu und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast Surgery, General Surgery, Cancer Center, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical C…. Hauptthemen laut MEDLINE: Lysosomes, Large Neutral Amino Acid-Transporter 1, Amino Acids, Membrane Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Foundation of Zhejiang Science and Technology Department "vanguard" "leading goose" Research, Key Discipline of Traditional Chinese Medicine in Zhejiang Province: Integrated Clinical Medicine (Oncology), National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Targeted degradation of membrane proteins via the lysosomal pathway holds great therapeutic promise, yet existing platforms rely on bulky ligands such as glycopolymers, antibodies, or protein nanocages, which complicate synthesis and limit tissue penetration. Here, we repurpose L‑type amino acid transporter 1 (LAT1)—a nutrient transporter overexpressed in diverse cancers—as a lysosomal targeting receptor. Taking advantage of LAT1‘s natural substrate preference, we design a minimalist chemical handle: a single phenylalanine derivative that serves as a high‑affinity LAT1 ligand. This ligand is conjugated via bioorthogonal chemistry to various warheads (antibodies or small molecules) to generate modular degraders termed LAT1‐mediated lysosome‐targeting chimeras (LA‑LYTAC). These chimeras efficiently internalize and route oncogenic membrane proteins—including PD‑L1, EGFR, and integrins—to lysosomes for degradation. The platform operates through a LAT1‑dependent, lysosomal mechanism and suppresses downstream signaling pathways. In a syngeneic mouse model of triple‑negative breast cancer, a PD‑L1‑targeting LA‑LYTAC reduces tumor growth by more than 60%, enhances CD8 + T cell infiltration, and shows no overt toxicity. This work establishes a synthetically accessible, truly modular, and tumor‑selective degradation platform driven by a single amino acid, offering a streamlined alternative to existing lysosome‑targeting technologies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LysosomesLarge Neutral Amino Acid-Transporter 1Amino AcidsMembrane ProteinsAnimalsMiceHumansLigandsProteolysisFemaleCell Line, TumorErbB Receptors

Stichwörter der Autor:innen

LAT1amino acid ligandlysosome‐targeting chimeramembrane protein degradationmodular degradation platformtargeted protein degradation

Substanzen

Large Neutral Amino Acid-Transporter 1LigandsAmino AcidsMembrane ProteinsErbB Receptors

Autor:innen und Institutionen

  • Department of Breast Surgery, General Surgery, Cancer Center, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, Zhejiang, China.
  • Key Laboratory for Diagnosis and Treatment of Upper Limb Edema and Stasis of Breast Cancer, Hangzhou, Zhejiang, China.
  • Central Laboratory, Department of Burn and Plastic Surgery-Hand Surgery, Changshu Hospital Affiliated to Soochow University, Changshu No.1 People's Hospital, Changshu, Jiangsu, China.

ORCID-Profile: Haotian Liu, Hongchao Tang, Da Qian, Xuli Meng

Förderung

  • Foundation of Zhejiang Science and Technology Department "vanguard" "leading goose" Research
  • Key Discipline of Traditional Chinese Medicine in Zhejiang Province: Integrated Clinical Medicine (Oncology)
  • National Natural Science Foundation of China
  • Zhejiang Province Traditional Chinese Medicine Science and Technology Plan Project
  • Zhejiang Provincial People's Hospital-Hangzhou Institute of Medicine, Chinese Academy of Sciences Joint Research Fund
  • Natural Science Foundation of Zhejiang province, China
  • Zhejiang Provincial Postdoctoral Science Foundation

Zitieren

APA

Zhu, L., Liu, K., Liu, H., He, C., Liu, X., Zeng, X., Mao, M., Mu, Y., Li, Y., Zheng, Q., Tang, H., Qian, D., & Meng, X. (2026). A Single‐Amino‐Acid Ligand for LAT1: A Minimalist and Modular Platform for Lysosome‐Targeted Degradation of Membrane Proteins. Advanced Science. https://doi.org/10.1002/advs.76862

Vancouver

Zhu L, Liu K, Liu H, He C, Liu X, Zeng X, et al. A Single‐Amino‐Acid Ligand for LAT1: A Minimalist and Modular Platform for Lysosome‐Targeted Degradation of Membrane Proteins. Advanced Science. 2026. doi:10.1002/advs.76862

BibTeX
@article{Zhu2026,
  author = {Zhu, Liquan and Liu, Ke and Liu, Haotian and He, Chaoqi and Liu, Xiaozhen and Zeng, Xin and Mao, Misha and Mu, Yuxiao and Li, Ying and Zheng, Qinghui and Tang, Hongchao and Qian, Da and Meng, Xuli},
  title = {A Single‐Amino‐Acid Ligand for LAT1: A Minimalist and Modular Platform for Lysosome‐Targeted Degradation of Membrane Proteins},
  journal = {Advanced Science},
  year = {2026},
  doi = {10.1002/advs.76862}
}
Kostenlos starten →